Light AI hires Emergo by UL to support regulatory submissions

Light AI, a Vancouver-based healthcare technology company, has partnered with Emergo by UL, an Austin, Texas-based regulatory compliance consulting firm specializing in the medical devices industry.

The partnership marks a new milestone in the commercialization journey of Light AI, which is listed on the CBOE stock exchange.

The firm (formerly Mojave Brands), is developing a diagnostics platform that applies AI algorithms to smartphone images to identify diseases – currently focusing on Group A Streptococcus.

Emergo by UL will initially help Light AI navigate regulatory submissions to Health Canada, and then help shape a global strategy for regulatory compliance.

“I am excited to have a talented group such as Emergo by UL support our submission development for Health Canada. They will also support in developing our global strategy of regulatory submissions,” Peter Whitehead, CEO of Light AI. “Emergo by UL's extensive experience and proven track record in the medical industry make them an invaluable partner as Light AI continues to expand its reach and impact across various international markets."

Emergo by UL provides an array of quality and regulatory compliance consulting offerings to medical devices companies, including medical device registration/approval, regulatory strategy, ISO 13485 and QMS compliance, local in-country representation, and post market surveillance.

The consultancy has more than 250 employees across 20+ global offices, including a Canadian location in Toronto.